3.8 Review

The severe COVID-19: A sepsis induced by viral infection? And its immunomodulatory therapy

Journal

CHINESE JOURNAL OF TRAUMATOLOGY
Volume 23, Issue 4, Pages 190-195

Publisher

ELSEVIER INC
DOI: 10.1016/j.cjtee.2020.06.002

Keywords

COVID-19; Sepsis; Immunomodulatory therapy; Immunotherapy; Ulinastatin; Thymosin a1

Categories

Ask authors/readers for more resources

COVID-19 is known for its magical infectivity, fast transmission and high death toll based on the large number of infected people. From the perspective of the clinical manifestation, autopsy examination and pathophysiology, the essence of COVID-19 should be viewed as a sepsis induced by viral infection, and has the essential characteristics as sepsis induced by other pathogens. Therefore, in addition to etiological and supportive treatment, immunomodulatory therapy is also appropriate to severe COVID-19. Although there is still a lack of consensus on immunotherapy for sepsis so far, relatively rich experiences have been accumulated in the past decades, which will help us in the treatment of severe COVID-19. This article will elaborate immunotherapy of sepsis, though it may not be consistent. (C) 2020 Production and hosting by Elsevier B.V. on behalf of Chinese Medical Association.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available